Market Cap 35.97B
Revenue (ttm) 19.67B
Net Income (ttm) 1.99B
EPS (ttm) N/A
PE Ratio 17.16
Forward PE 15.95
Profit Margin 10.13%
Debt to Equity Ratio 1.18
Volume 3,352,400
Avg Vol 3,482,982
Day's Range N/A - N/A
Shares Out 455.52M
Stochastic %K 44%
Beta 1.08
Analysts Strong Sell
Price Target $92.30

Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning,...

Industry: Health Information Services
Sector: Healthcare
Phone: 833 735 1139
Address:
500 West Monroe Street, Chicago, United States
parcha
parcha Feb. 1 at 2:25 AM
$GEHC Investment Alert Comparison Ratio Update for GE Healthcare Technologies Inc GEHC's ROE is among the highest in the Health Care Equipment industry. Moreover, with a capital structure and revenue growth that are appropriate for the industry, management seems to be effective at utilizing its available resources.
0 · Reply
Estimize
Estimize Jan. 29 at 1:03 PM
Wall St is expecting 1.40 EPS for $GEHC Q4 [Reporting 02/04 BMO] http://www.estimize.com/intro/gehc?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 28 at 12:59 AM
$GEHC Share Price: $80.29 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.36 – $5.33 Potential Upside: 62% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 2:36 PM
$GEHC Share Price: $79.77 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $2.25 – $2.78 Target Zone: $4.07 – $4.97 Potential Upside: 71% ROI Time to Expiration: 26 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JamesPond007
JamesPond007 Jan. 21 at 12:53 AM
$GEHC dear UBS
0 · Reply
parcha
parcha Jan. 19 at 7:37 PM
0 · Reply
parcha
parcha Jan. 17 at 2:14 PM
$GEHC NXP Semiconductors and GE HealthCare announced a collaboration to advance edge AI in medical settings, showcasing new anesthesia and neonatal care concepts at CES 2026 that use on-device processing for real-time clinical support. The partnership underscores how locally processed, voice- and vision-based AI could change operating room workflows and neonatal monitoring while adhering to GE HealthCare’s Responsible AI principles around safety, privacy, and fairness. We’ll now examine how this edge AI collaboration, particularly the anesthesia voice-control concept, may influence GE HealthCare’s broader investment narrative. https://finance.yahoo.com/news/ge-healthcare-gehc-using-edge-151046205.html
0 · Reply
JamesPond007
JamesPond007 Jan. 16 at 3:15 PM
$GEHC UBS downgrades but sell should not happen before news ... Earnings in 2 weeks
0 · Reply
KimberlyMcKenzie5
KimberlyMcKenzie5 Jan. 15 at 6:13 PM
$GEHC healthcare spin, trend confirmation if buyers defend higher lows
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 3:26 PM
Data is becoming the next profit engine in medtech — and these names are leading the charge. 📊🧠 $MDT, $IQV and $GEHC are showing how analytics, AI, and enterprise data platforms can be monetized into recurring revenue streams, pushing medical devices beyond just hardware. See how data + AI are reshaping revenue models in medtech 👉 https://www.zacks.com/stock/news/2818016/3-medical-device-companies-in-focus-for-monetizing-data-and-analytics?cid=sm-stocktwits-2-2818016-teaser-29098&ADID=SYND_STOCKTWITS_TWEET_2_2818016_TEASER_29098
0 · Reply
Latest News on GEHC
3 S&P 500 Stocks to Sell in 2026

Jan 16, 2026, 7:16 PM EST - 17 days ago

3 S&P 500 Stocks to Sell in 2026

TSLA UNH


Sell GE HealthCare Stock, UBS Says. The Risks Aren't Known.

Jan 15, 2026, 11:09 AM EST - 19 days ago

Sell GE HealthCare Stock, UBS Says. The Risks Aren't Known.


GE HealthCare announces cash dividend for fourth quarter of 2025

Nov 24, 2025, 5:15 PM EST - 2 months ago

GE HealthCare announces cash dividend for fourth quarter of 2025


GE HealthCare to Acquire Intelerad for $2.3 Billion

Nov 20, 2025, 5:43 PM EST - 2 months ago

GE HealthCare to Acquire Intelerad for $2.3 Billion


GE Healthcare to acquire Intelerad for $2.3 billion

Nov 20, 2025, 4:12 PM EST - 2 months ago

GE Healthcare to acquire Intelerad for $2.3 billion


Tariffs Bite Into GE HealthCare Q3 Profit Margin

Oct 29, 2025, 11:42 AM EDT - 3 months ago

Tariffs Bite Into GE HealthCare Q3 Profit Margin


GE HealthCare Tech Profit Slides as Tariffs Drag

Oct 29, 2025, 7:33 AM EDT - 3 months ago

GE HealthCare Tech Profit Slides as Tariffs Drag


GE HealthCare reports third quarter 2025 financial results

Oct 29, 2025, 6:20 AM EDT - 3 months ago

GE HealthCare reports third quarter 2025 financial results


GE HealthCare announces cash dividend for third quarter of 2025

Sep 24, 2025, 3:58 PM EDT - 4 months ago

GE HealthCare announces cash dividend for third quarter of 2025


GE Healthcare exploring sale of China unit, source says

Sep 19, 2025, 2:20 AM EDT - 4 months ago

GE Healthcare exploring sale of China unit, source says


GE HealthCare: This Drop Represents A Buying Opportunity

Jul 31, 2025, 3:48 AM EDT - 6 months ago

GE HealthCare: This Drop Represents A Buying Opportunity


parcha
parcha Feb. 1 at 2:25 AM
$GEHC Investment Alert Comparison Ratio Update for GE Healthcare Technologies Inc GEHC's ROE is among the highest in the Health Care Equipment industry. Moreover, with a capital structure and revenue growth that are appropriate for the industry, management seems to be effective at utilizing its available resources.
0 · Reply
Estimize
Estimize Jan. 29 at 1:03 PM
Wall St is expecting 1.40 EPS for $GEHC Q4 [Reporting 02/04 BMO] http://www.estimize.com/intro/gehc?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 28 at 12:59 AM
$GEHC Share Price: $80.29 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.36 – $5.33 Potential Upside: 62% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 2:36 PM
$GEHC Share Price: $79.77 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $2.25 – $2.78 Target Zone: $4.07 – $4.97 Potential Upside: 71% ROI Time to Expiration: 26 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JamesPond007
JamesPond007 Jan. 21 at 12:53 AM
$GEHC dear UBS
0 · Reply
parcha
parcha Jan. 19 at 7:37 PM
0 · Reply
parcha
parcha Jan. 17 at 2:14 PM
$GEHC NXP Semiconductors and GE HealthCare announced a collaboration to advance edge AI in medical settings, showcasing new anesthesia and neonatal care concepts at CES 2026 that use on-device processing for real-time clinical support. The partnership underscores how locally processed, voice- and vision-based AI could change operating room workflows and neonatal monitoring while adhering to GE HealthCare’s Responsible AI principles around safety, privacy, and fairness. We’ll now examine how this edge AI collaboration, particularly the anesthesia voice-control concept, may influence GE HealthCare’s broader investment narrative. https://finance.yahoo.com/news/ge-healthcare-gehc-using-edge-151046205.html
0 · Reply
JamesPond007
JamesPond007 Jan. 16 at 3:15 PM
$GEHC UBS downgrades but sell should not happen before news ... Earnings in 2 weeks
0 · Reply
KimberlyMcKenzie5
KimberlyMcKenzie5 Jan. 15 at 6:13 PM
$GEHC healthcare spin, trend confirmation if buyers defend higher lows
0 · Reply
ZacksResearch
ZacksResearch Jan. 15 at 3:26 PM
Data is becoming the next profit engine in medtech — and these names are leading the charge. 📊🧠 $MDT, $IQV and $GEHC are showing how analytics, AI, and enterprise data platforms can be monetized into recurring revenue streams, pushing medical devices beyond just hardware. See how data + AI are reshaping revenue models in medtech 👉 https://www.zacks.com/stock/news/2818016/3-medical-device-companies-in-focus-for-monetizing-data-and-analytics?cid=sm-stocktwits-2-2818016-teaser-29098&ADID=SYND_STOCKTWITS_TWEET_2_2818016_TEASER_29098
0 · Reply
parcha
parcha Jan. 15 at 2:26 PM
$GEHC UBS Downgrades GE Healthcare Technologies to Sell From Neutral, Adjusts Price Target to $77 From $73 January 15, 2026 05:23 AM ETPublished January 15, 2026 05:23 AM Eastern TimeMT Newswires 05:23 AM EST, 01/15/2026 (MT Newswires) -- GE Healthcare Technologies (GEHC) has an average rating of overweight and mean price target of $91.56, according to analysts polled by FactSet.
0 · Reply
briefingcom
briefingcom Jan. 15 at 1:34 PM
$GEHC: GE HealthCare downgraded to Sell from Neutral at UBS, tgt $77 https://www.briefing.com/calendars/updown?Filter=All&utm_campaign=updown&utm_medium=social&utm_source=x&utm_content=link
0 · Reply
theflynews
theflynews Jan. 15 at 9:43 AM
GE HealthCare just downgraded at UBS, here's why - $GEHC - https://thefly.com/permalinks/entry.php/GEHCid4271664?1768469987C38
0 · Reply
traderheadnyc
traderheadnyc Jan. 14 at 2:59 PM
$GEHC Watch out for this company - may drop under 75
0 · Reply
ZacksResearch
ZacksResearch Jan. 12 at 2:23 PM
$TEM: Is it time to take profits after a 105% gain? 📈 Tempus AI has soared over the past year, driven by strong performance in its Genomics and Data segments, outperforming the industry, S&P 500, and rivals like $EXAS and $GEHC, thanks to FDA approvals and AI demand. Despite the positive adjusted EBITDA, GAAP losses and stock-based compensation remain concerns. See what could impact TEM's next move 👉 https://www.zacks.com/stock/news/2815490/tempus-ai-stock-rallies-105-in-a-year-should-investors-still-hold?cid=sm-stocktwits-2-2815490-body-28364&ADID=SYND_STOCKTWITS_TWEET_2_2815490_BODY_28364
0 · Reply
parcha
parcha Jan. 11 at 4:13 PM
$GEHC Stifel raised the firm’s price target on GE HealthCare (GEHC) to $95 from $90 and keeps a Buy rating on the shares. The firm, which argues that the 2026 setup is constructive for large-cap MedTech following 2025 pressures, adjusted targets among its coverage and highlights Boston Scientific (BSX), Edwards Lifesciences (EW), and Solventum (SOLV) as its three top ideas entering the year. https://finance.yahoo.com/news/ge-healthcare-price-target-raised-124143161.html
0 · Reply
parcha
parcha Jan. 10 at 8:43 PM
$GEHC this Tuesday
0 · Reply
parcha
parcha Jan. 10 at 8:42 PM
$GEHC Friday was Ex-Dividend Date 01/09/2026 · Dividend Yield 0.16% · Annual Dividend $0.14 . Payment Friday, Feb 13
0 · Reply
D6975
D6975 Jan. 9 at 11:32 PM
$GEHC why won’t this stock act more like $GE and $GEV
1 · Reply
parcha
parcha Jan. 8 at 6:51 PM
https://youtube.com/watch?v=vkHTvOVF-kc&si=osvLuYSUhP9f_Pw2 $GEHC Healthcare Sector (4:58-5:36): Newton sees good strength in healthcare, particularly in medical devices and biotech for long exposure over the next month. He suggests switching to a more pharma-centric approach thereafter. Overall, healthcare is not a true overweight and requires selectivity.
0 · Reply
parcha
parcha Jan. 7 at 3:17 AM
$GEHC https://finance.yahoo.com/news/nxp-ge-healthcare-accelerate-ai-160000907.html
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 4 at 5:19 PM
$GEHC GE HealthCare Technologies Inc (NASDAQ:GEHC) operates at the center of medical technology, patient monitoring equipment, diagnostic imaging, and digital solutions that enable hospitals and clinicians to improve outcomes and deliver better care across the world. https://biotechhealthx.com/biotech-news/why-ge-healthcare-technologies-gehc-could-be-the-hidden-giant-behind-the-future-of-global-healthcare/
0 · Reply